Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of deferitrin in beta-thalassemia patients with iron overload
2004-002173-23Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Deferitrin in iron overload and beta thalassemia, sponsored by Sanofi. Started Apr 2005; status: terminated.
02
Drugs
Deferitrin
03
Conditions
iron overloadbeta thalassemia
Beyond the preview
Go deeper on 2004-002173-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002173-23.